AP NEWS

Latest Trends in Sexual Health Dealmaking in the Biopharma Industry Since 2012 - ResearchAndMarkets.com

September 18, 2018

DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Sexual Health Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.

The Global Sexual Health Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Sexual Health partnering deals and agreements entered into by the world’s leading healthcare companies.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.

The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope

Trends in Sexual Health dealmaking in the biopharma industry since 2012 Analysis of Sexual Health deal structure Access to headline, upfront, milestone and royalty data The leading Sexual Health deals by value since 2012

Available deals are listed by:

Company A-Z Headline value Stage of development at signing Deal component type Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sexual Health dealmaking

Chapter 3 - Financial deal terms for Sexual Health partnering

Chapter 4 - Leading Sexual Health deals and dealmakers

Chapter 5 - Sexual Health contract document directory

Chapter 6 - Sexual Health dealmaking by therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/h97gkd/latest_trends_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180918006113/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Sexual and Reproductive Health Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/18/2018 05:04 PM/DISC: 09/18/2018 05:04 PM

http://www.businesswire.com/news/home/20180918006113/en

AP RADIO
Update hourly